Related topics: multiple sclerosis
MSNBC
hideMSNBC is a 24-hour cable news channel based in the United States and available in both the US and Canada. Its name is a combination of "MSN" and "NBC".
Msnbc.com, a separate company, is the news website for the NBC News family, featuring interactivity and multimedia plus original stories and video which augment the content from NBC News and partners.
Two partnerships with the names MSNBC and msnbc.com were founded in 1996 by Microsoft and General Electric's NBC unit, which is now NBC Universal. Although Microsoft and NBC shared operations of MSNBC cable at its founding, it was announced on December 23, 2005, that NBC Universal would purchase a majority stake in the television network, which left Microsoft with 18%. The two companies remain 50-50 partners in msnbc.com. MSNBC shares the NBC logo of a rainbow peacock with its sister channels NBC, CNBC and ShopNBC.
Critics and observers of the network say that MSNBC has become increasingly politically liberal compared with other networks, particularly in its prime-time lineup.
For more information about MSNBC, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with ms
What part do relapses play in severe disability for people with MS?
Medicine & Health / Neuroscience
Nov 04, 2009 |
5 / 5 (1) |
0
ST. PAUL, Minn. -People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according ...
Aussie and Kiwi researchers make double MS genetic discovery
Jun 14, 2009 |
5 / 5 (1) |
0
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.
Risk of leukemia with multiple sclerosis drug higher than thought
Apr 30, 2009 |
not rated yet |
1
The risk of developing leukemia as a side effect of a drug for multiple sclerosis (MS) is higher than previously reported, according to a study to be presented as part of the Late-breaking Science Program at the American ...
Adding steroid drug to MS treatment may reduce disease activity
Apr 30, 2009 |
5 / 5 (2) |
0
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone, according to a study that will be presented as part of the Late-breaking ...
New pill to treat multiple sclerosis
Medicine & Health / Medications
Apr 30, 2009 |
3.3 / 5 (4) |
0
A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.
Stem cells from fat tissue offer hope for MS treatment
Apr 24, 2009 |
5 / 5 (3) |
0
A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open ...
'Buckyballs' to treat multiple sclerosis
Nanotechnology / Bio & Medicine
Mar 19, 2009 |
5 / 5 (2) |
1
If you're of a certain age, you'll remember Buckminster Fuller's distinctive "geodesic domes" - soccer-ball-shaped structures that the late futurist envisioned as ideal human domiciles. Tel Aviv University ...
Hookworms in MS trial
Mar 03, 2009 |
not rated yet |
0
Scientists from The University of Nottingham will study the potential health benefits of parasitic worms as part of a study investigating treatments for people with the autoimmune condition multiple sclerosis (MS).
Epstein-Barr virus may be associated with progression of MS
Medicine & Health / Neuroscience
Mar 02, 2009 |
5 / 5 (1) |
0
Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University ...
Drug improves mobility for some MS patients
Medicine & Health / Medications
Feb 27, 2009 |
4.5 / 5 (2) |
0
The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published ...
Young smokers increase risk for multiple sclerosis
Feb 23, 2009 |
not rated yet |
0
People who start smoking before age 17 may increase their risk for developing multiple sclerosis (MS), according to a study released today that will be presented at the American Academy of Neurology's 61st Annual Meeting ...
Can breastfeeding reduce multiple sclerosis relapses?
Feb 19, 2009 |
5 / 5 (1) |
0
Women who have multiple sclerosis may reduce their risk of relapses after pregnancy if they breastfeed their babies, according to a study released today that will be presented at the American Academy of Neurology's 61st Annual ...
Genetic study shows direct link between vitamin D and MS susceptibility 'gene'
Feb 05, 2009 |
5 / 5 (1) |
0
Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS). The research, published on 6 February in the open-access journal ...
Relapses more frequent in patients diagnosed with pediatric-onset multiple sclerosis
Jan 12, 2009 |
not rated yet |
0
Patients who develop multiple sclerosis before age 18 appear to experience more relapses of symptoms than those diagnosed with the disease as adults, according to a report in the January issue of Archives of Neurology.
If MRI shows signs of MS, will the disease develop?
Dec 10, 2008 |
5 / 5 (1) |
0
With more and more people having brain MRIs for various reasons, doctors are finding people whose scans show signs of multiple sclerosis (MS) even though they have no symptoms of the disease. A new study published in the ...
